Literature DB >> 26605500

Multi-Informant Assessment of ADHD Symptom-Related Impairments Among Children and Adolescents.

Thomas J Power1, Marley W Watkins2, Arthur D Anastopoulos3, Robert Reid4, Mathew C Lambert4, George J DuPaul5.   

Abstract

Existing methods of assessing attention-deficit/hyperactivity disorder (ADHD) are limited because they do not examine impairments in relation to symptoms of ADHD. This study investigated parent and teacher ratings of multiple domains of impairment, assessed in relation to the symptom dimensions of ADHD using the ADHD Rating Scale-5. Nationally representative samples of children rated by parents and teachers were recruited through commercial research firms. One sample included 2,079 parents who rated one of their children of age 5 to 17 years. The second sample included 1,070 teachers in grades K to 12 who rated 2 randomly selected students on their class rosters. Informants rated the extent to which each child displayed the 18 behaviors symptomatic of ADHD over the previous 6 months, as well as symptom-related impairments in the areas of family/teacher relationships, peer relationships, academics, behavior problems, homework, and self-esteem. Respondents were asked to complete the 6 impairment items after rating each of the Inattention and Hyperactivity/Impulsivity symptom items. For both informants a 6-factor model that combined impairment items across source of impairment was adequate and superior to a 2-factor structure based on source of impairment (i.e., impairment due to Inattention vs. Hyperactivity-Impulsivity). Impairment ratings were impacted by child demographic factors, but effect sizes were low. In contrast, impairment ratings were strongly related to ratings on the ADHD symptom dimensions. The study provides support for assessing 6 symptom-related domains of impairment but does not support differentiating whether Inattention or Hyperactivity-Impulsivity is the source of impairment.

Entities:  

Mesh:

Year:  2015        PMID: 26605500     DOI: 10.1080/15374416.2015.1079781

Source DB:  PubMed          Journal:  J Clin Child Adolesc Psychol        ISSN: 1537-4416


  7 in total

1.  Making the Most of It: Application of Planned Missingness Design to Increase the Efficiency of Diagnostic Assessment.

Authors:  Zvi R Shapiro; Cynthia Huang-Pollock; John W Graham; Kristina Neely
Journal:  J Psychopathol Behav Assess       Date:  2020-01-08

2.  ADHD Parent and Teacher Symptom Ratings: Differential Item Functioning across Gender, Age, Race, and Ethnicity.

Authors:  George J DuPaul; Qiong Fu; Arthur D Anastopoulos; Robert Reid; Thomas J Power
Journal:  J Abnorm Child Psychol       Date:  2020-05

3.  Distance-Learning, ADHD Quality Improvement in Primary Care: A Cluster-Randomized Trial.

Authors:  Alexander G Fiks; Stephanie L Mayne; Jeremy J Michel; Jeffrey Miller; Manju Abraham; Andrew Suh; Abbas F Jawad; James P Guevara; Robert W Grundmeier; Nathan J Blum; Thomas J Power
Journal:  J Dev Behav Pediatr       Date:  2017-10       Impact factor: 2.225

4.  High-End Specificity of the Attention-Deficit/Hyperactivity Problems Scale of the Child Behavior Checklist for Ages 1.5-5 in a Sample of Young Children with Disruptive Behavior Disorders.

Authors:  Natalie Hong; Jonathan S Comer
Journal:  Child Psychiatry Hum Dev       Date:  2019-04

5.  Barriers and Facilitators to Teachers' Use of Behavioral Classroom Interventions.

Authors:  Gwendolyn M Lawson; Julie Sarno Owens; David S Mandell; Samantha Tavlin; Steven Rufe; Amy So; Thomas J Power
Journal:  School Ment Health       Date:  2022-05-26

6.  Psychometric Properties of ADHD Rating Scale-5 for Children and Adolescents in Sudan-School Version.

Authors:  Abdulkarim Alhossein; Abdulrahman Abdullah Abaoud; David Becker; Rashed Aldabas; Salaheldin Farah Bakhiet; Mohammed Al Jaffal; Manar Alsufyani; Nagda Mohamed Abdu Elrahim; Nouf Alzrayer
Journal:  Front Psychol       Date:  2022-06-27

7.  The Effect of Viloxazine Extended-Release Capsules on Functional Impairments Associated with Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents in Four Phase 3 Placebo-Controlled Trials.

Authors:  Azmi Nasser; Joseph T Hull; Tesfaye Liranso; Gregory D Busse; Zare Melyan; Ann C Childress; Frank A Lopez; Jonathan Rubin
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-03       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.